PO.TB10.05 · 肿瘤生物学
可改变的生活方式因素与乳腺肿瘤及癌旁正常组织中的免疫基因表达
Modifiable lifestyle factors and immune gene expression in breast tumor and normal-adjacent tissue
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:肿瘤免疫微环境可能为乳腺癌预后提供关键信息。多种可改变的风险因素会影响免疫应答,包括体重、体力活动和饮食;然而,这些因素是否会改变乳腺肿瘤免疫微环境仍属未知。
方法:纳入了参加护士健康研究(Nurses' Health Studies)、被诊断为浸润性乳腺癌且有可用肿瘤组织和/或癌旁正常组织的受试者(N=945)。使用CIBERSORTx对免疫细胞丰度进行反卷积分析。针对免疫谱的各组分(如免疫检查点标志物、共调节信号与抗原呈递、以及细胞因子信号传导)推导基因表达特征。通过每两年一次的问卷收集受试者的体重、BMI、饮酒情况和吸烟状态。总体饮食通过替代健康饮食指数(AHEI)和经验性饮食炎症模式(EDIP)加以概括,二者来源于每4年填写一次的食物频率问卷。采用线性回归检验诊断前暴露(来自最接近诊断时间的问卷)与免疫细胞丰度及基因表达之间的关联。肿瘤组织与癌旁正常组织分别进行分析。模型校正了诊断年份和诊断年龄、绝经状态以及雌激素受体(ER)状态。免疫组分的多重检验通过错误发现率加以控制。模型还按ER和绝经状态进行分层。
结果:在875名有可用肿瘤组织的女性中,诊断时的平均年龄为59岁(SD=11.4)。多数(73%)为绝经后女性,肿瘤为ER阳性(77%),诊断时为1-2期(91%)。在绝经后女性的ER阳性肿瘤组织中,18岁以后的体重增加与干扰素信号传导、MHCII和PD1表达呈正相关(校正后p均<0.05)。在该组中,较高的体力活动与CD8:CD68比值升高相关。在绝经前和绝经后女性的ER阴性肿瘤组织中,每周饮酒量增加与较高的PDL1和较低的CSR表达相关。在癌旁正常组织中,当前吸烟与绝经前女性细胞因子信号传导增强相关,而总吸烟包年数与绝经后女性较高的浆细胞B细胞相关。较高的EDIP与ER阴性肿瘤组织中MHCII和IL12表达升高相关,而较高的AHEI与癌旁正常组织中较低的淋巴细胞浸润表达相关,且不受绝经状态影响。
结论:体重增加、吸烟、饮酒和饮食(AHEI和EDIP)与乳腺癌免疫微环境的差异相关,且这些关联因ER和绝经状态而异。生活方式行为的改变可能影响肿瘤免疫应答并影响患者预后,但仍需进一步研究。
查看英文原文 English abstract
Background: The tumor immune microenvironment may provide key information on breast cancer prognosis. Several modifiable risk factors influence the immune response, including weight, physical activity, and diet; however, whether these factors alter the breast tumor immune microenvironment remains unknown.
Methods: Participants enrolled in the Nurses' Health Studies diagnosed with invasive breast cancer and available tumor and/or normal adjacent tissue were included (N=945). Immune cell abundance was deconvoluted using CIBERSORTx. Gene expression signatures were derived for components of the immune profile such as immune checkpoint markers, co-regulatory signal and antigen presentation, and cytokine signaling. Participant weight, BMI, alcohol use, and smoking status were collected via bi-annual questionnaires. Overall diet was summarized by the alternative healthy eating index (AHEI) and the empirical dietary inflammatory pattern (EDIP), derived from food frequency questionnaires completed every 4 years. Linear regression was used to test the association between pre-diagnostic exposures (from questionnaires closest to diagnosis) and immune cell abundance and gene expression. Tumor and normal-adjacent tissue were analyzed separately. Models were adjusted for year and age of diagnosis, menopausal status, and estrogen-receptor (ER) status. Multiple testing of immune components was controlled via the false discovery rate. Models were also stratified by ER and menopausal status.
Results: Among 875 women with available tumor tissue, mean age at diagnosis was 59 years (SD=11.4). The majority (73%) were post-menopausal, had ER-positive tumors (77%), and were diagnosed at stage 1-2 (91%). In ER-positive tumor tissue of postmenopausal women, weight gain since age 18 was positively associated with interferon signaling, MHCII, and PD1 expression (all p adj <0.05). Higher physical activity was associated with enriched CD8:CD68 ratio in this group. In ER-negative tumor tissue of pre- and postmenopausal women, consuming more drinks per week was associated with higher PDL1 and lower CSR expression. In normal-adjacent tissue, current smoking was associated with enriched cytokine signaling in premenopausal women and total pack-years was associated with higher B cell plasma in postmenopausal women. Higher EDIP was associated with heightened MHCII and IL12 expression in ER-negative tumor tissue while higher AHEI was associated with lower lymphocyte infiltration expression in normal adjacent tissue, regardless of menopausal status.
Conclusions: Weight gain, smoking, alcohol use, and diet (AHEI and EDIP) are associated with differences in the breast cancer immune microenvironment, with distinct associations by ER and menopausal status. Changes in lifestyle behaviors may influence the tumor immune response and impact patient prognosis, though further studies are needed.
利益披露 Disclosure
K. D. Brantley, None..
C. Peng, None..
C. Bodelon, None..
D. A. Tadesse, None..
P. Kraft, None..
R. M. Tamimi, None.